Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: Insights from the SAFEHEART registry (Spanish familial hypercholesterolaemia cohort study)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 9, 2016, Pages 2004-2010

  De Isla, Leopoldo Pérez ^a,b   Alonso, Rodrigo ^b,c   Mata, Nelva ^b,d   Saltijeral, Adriana ^b,e   Muñiz, Ovidio ^f   Rubio Marin, Patricia ^g   Diaz Diaz, José L ^h   Fuentes, Francisco ⁱ   De Andrés, Raimundo ^j   Zambón, Daniel ^k   Galiana, Jesús ^l   Piedecausa, Mar ^m   Aguado, Rocio ⁿ   Mosquera, Daniel ^o   Vidal, José I ^p   Ruiz, Enrique ^q   Manjón, Laura ^r   Mauri, Marta ^s   Padró, Teresa ^t   Miramontes, José P ^u   Mata, Pedro ^b   more..

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Medicina Interna   (Spain)

^c CLÍNICA LAS CONDES   (Chile)

^d Madrid Regional Authority   (Spain)

^e España Electronic address: juanmartinnav hotmailcom   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL DE JEREZ   (Spain)

^h Hospital Abente y Lago   (Spain)

ⁱ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^j Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l Hospital Universitario de Ciudad Real   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

ⁿ Hospital General de Leon   (Spain)

^o HOSPITAL SAN PEDRO   (Spain)

^p Hospital de Lugo   (Spain)

^q HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^r Hospital Cabueñes Gijón   (Spain)

^s HOSPITAL DE TERRASSA   (Spain)

^t Institut Català de Ciències Cardiovasculars   (Spain)

^u Hospital Univeritario   (Spain)

more..

Author keywords

Coronary disease; Genetics; Hypercholesterolemia; Peripheral vascular diseases; Stroke

Indexed keywords

ANTILIPEMIC AGENT; LIPOPROTEIN A; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100; LDLR PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGE; APOB GENE; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENE MUTATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX; SMOKING HABIT; TOBACCO; ADVERSE EFFECTS; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COMORBIDITY; CORONARY DISEASE; GENETIC PREDISPOSITION; GENETICS; HEREDITY; HETEROZYGOTE; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; MUTATION; ONSET AGE; PEDIGREE; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPAIN; STROKE;

ADULT; AGE OF ONSET; AGED; APOLIPOPROTEIN B-100; CASE-CONTROL STUDIES; COMORBIDITY; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MUTATION; PEDIGREE; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, LDL; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING; SPAIN; STROKE;

EID: 84979707978     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307514     Document Type: Article

References (19)

1. Austin MA, Hutter CM, Zimmern RL, Humphries SE, Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review. Am J Epidemiol 2004 160 407 420. doi: 10.1093/aje/kwh236
2. Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF, Wierzbicki AS, American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health The agenda for familial hypercholesterolemia: A scientific statement from the American Heart Association. Circulation 2015 132 2167 2192. doi: 10.1161/CIR.0000000000000297
3. Slack J, Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 1969 2 1380 1382
4. Hutter CM, Austin MA, Humphries SE, Familial hypercholesterolemia, peripheral arterial disease, and stroke: A HuGE minireview. Am J Epidemiol 2004 160 430 435. doi: 10.1093/aje/kwh238
5. Mata P, Alonso R, Pérez-Jiménez F, Screening for familial hypercholesterolemia: A model for preventive medicine. Rev Esp Cardiol (Engl Ed) 2014 67 685 688. doi: 10.1016/j.rec.2014.01.015
6. Jansen AC, van Wissen S, Defesche JC, Kastelein JJ, Phenotypic variability in familial hypercholesterolaemia: An update. Curr Opin Lipidol 2002 13 165 171
7. Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P, SAFEHEART Investigators Lipoprotein(a) levels in familial hypercholesterolemia: An important predictor of cardiovascular disease independent of the type of LDL receptor mutation. J Am Coll Cardiol 2014 63 1982 1989. doi: 10.1016/j.jacc.2014.01.063
8. Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR, Soutar AK, Phenotypic variation in heterozygous familial hypercholesterolemia: A comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol 1998 18 309 315
9. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG, Familial hypercholesterolemia in the Danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012 97 3956 3964. doi: 10.1210/jc.2012-1563
10. deGoma EM, Ahmad ZS, O'Brien EC, Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. Circ Cardiovasc Genet 2016 9 240 249. doi: 10.1161/CIRCGENETICS.116.001381
11. Alonso R, Mata N, Castillo S, Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 2000, 200 315 321
12. Allard MD, Saeedi R, Yousefi M, Frohlich J, Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort. Lipids Health Dis 2014 13 65. doi: 10.1186/1476-511X-13-65
13. Khera AV, Won HH, Peloso GM, Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol 2016 67 2578 2589. doi: 10.1016/j.jacc.2016.03.520
14. Barkas F, Elisaf M, Milionis H, Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-Analysis. Atherosclerosis 2015 243 60 64. doi: 10.1016/j.atherosclerosis.2015.08.038
15. Mabuchi H, Miyamoto S, Ueda K, Oota M, Takegoshi T, Wakasugi T, Takeda R, Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986 61 1 6
16. Huxley RR, Hawkins MH, Humphries SE, Karpe F, Neil HA, Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee Risk of fatal stroke in patients with treated familial hypercholesterolemia: A prospective registry study. Stroke 2003 34 22 25
17. Kroon AA, Ajubi N, van Asten WN, Stalenhoef AF, The prevalence of peripheral vascular disease in familial hypercholesterolaemia. J Intern Med 1995 238 451 459
18. Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ, Sijbrands EJ, Efficacy of statins in familial hypercholesterolaemia: A long term cohort study. BMJ 2008 337 a2423
19. Cannon CP, Blazing MA, Giugliano RP, IMPROVE-IT Investigators Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015 372 2387 2397. doi: 10.1056/NEJMoa1410489